Added to YB: 2024-04-11
Pitch date: 2024-04-11
TGTX [bullish]
TG Therapeutics, Inc.
+99.59%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.
Market Cap
$4.2B
Pitch Price
$14.76
Price Target
N/A
Dividend
N/A
EV/EBITDA
40.90
P/E
10.27
EV/Sales
8.06
Sector
Biotechnology
Category
N/A
Show full summary:
TG THERAPEUTICS INC TGTX
A summary for this pitch has not been created yet.
Read full article (0 min)